Hjem › Autoimmune sygdomme › North Carolina
Autoimmune sygdomme kliniske forsøg i North Carolina
18 studier for Autoimmune sygdomme søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
Environmental Risk Factors for the Anti-synthetase Syndrome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT01276470Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- On Site Clinical Solutions Llc, Charlotte
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07621809A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252Daratumumab in Primary Antiphospholipid Syndrome
- Duke University, Durham
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT05671757A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 11. sep. 2026 · NCT07059000A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06948318A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Durham
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Duke University, Durham
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-108, Greenville
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 31. jul. 2026 · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT07115745A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital, Charlotte
- Duke University Medical Center, Durham
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Kvinder · Opdateret 8. jan. 2026 · NCT03276923Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.